Oximetazolina Farmoz (Oxymetazoline Hydrochloride)

Oxymetazoline acts on the nasal mucosa to reduce swelling and improve airflow. It is commonly used for:

• Common Cold: Relieves nasal congestion and improves breathing.
• Allergic Rhinitis: Decreases nasal blockage caused by seasonal allergens.
• Sinusitis: Alleviates congestion associated with acute sinus inflammation.
• Nasal Surgery Recovery: Helps maintain clear airways post‑operatively.

• Oxymetazoline is a selective alpha‑1 and alpha‑2 adrenergic receptor agonist. By stimulating these receptors on the smooth muscle of nasal blood vessels, it causes vasoconstriction, which reduces mucosal edema and limits excess secretions, thereby opening the nasal airway.

Oxymetazoline nasal spray may cause a range of adverse reactions. Most are mild and reversible.

Common Side Effects

• Burning or stinging sensation in the nose
• Mild headache
• Nasal dryness or irritation
• Sneezing
• Transient nasal bleeding
• Unpleasant taste

Serious or Rare Side Effects

• Persistent nasal congestion (rebound congestion) with prolonged use
• Severe hypertension
• Cardiac arrhythmias
• Allergic reactions such as rash, itching, or swelling
• Nasal ulceration
• Vision changes

When using Oximetazolina Farmoz, consider the following safety measures:

• Limit Duration: Do not exceed three consecutive days of use to avoid rebound congestion.
• Underlying Conditions: Use with caution in patients with hypertension, cardiovascular disease, diabetes, hyperthyroidism, or glaucoma.
• Pediatric Use: Not recommended for children under six years of age.
• Pregnancy & Lactation: Consult a healthcare professional before use during pregnancy or while breastfeeding.
• Drug Interactions: Review concomitant medications, especially monoamine oxidase inhibitors (MAOIs) and other vasoconstrictors.
• Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Oxymetazoline may interact with several drug classes. Awareness of these interactions helps maintain safety.

Major Interactions (Avoid)

• MAOIs: Increased risk of hypertensive crisis.
• Systemic Decongestants: Additive vasoconstrictive effects leading to elevated blood pressure.

Moderate Interactions (Monitor Closely)

• Antihypertensive agents: May reduce the effectiveness of blood‑pressure‑lowering therapy.
• Tricyclic antidepressants: Potential for enhanced cardiovascular stimulation.
• Beta‑blockers: May increase the risk of tachycardia.
• Nasal corticosteroids: Generally safe but monitor for increased local irritation.